Expression of Anaplastic Lymphoma Kinase and Survivin Proteins in Anaplastic Large Cell Lymphoma and Its Significance

Jin-fan Li,Gan-di Li,Wei-ping Liu,Ying Wang,Ji-rong Cheng,Yu Chen,Hong Yang,He-lian Tang,Yan-qiong Bai,De-guang Lin,Li-hui DU,Feng-xiang Peng,Yong-hong Yang,Chun Zhao

DOI: https://doi.org/10.3760/j.issn:0529-5807.2006.04.005

2006-01-01

Abstract:OBJECTIVE:To study the expression of anaplastic lymphoma kinase (ALK) and survivin proteins in anaplastic large cell lymphoma (ALCL) and there clinical significance. METHODS:The morphologic characteristics were studied by routine light microscopy. Immunohistochemical staining for ALK and survivin proteins was performed using LSAB method. RESULTS:ALK protein was positive in 51 cases (63%) and negative in 30 cases (37%) of the 81 cases of ALCL studied. The prognosis of patients with ALK protein expression was better than those without ALK expression (P < 0.05). As for survivin protein, there were various degrees of expression in all the 77 ALCL cases studied. High level of survivin protein expression was observed in 33 cases (42.9%), while low level of expression was seen in 44 cases (57.1%). The expression of survivin protein did not correlate with that of ALK protein (P > 0.05). The survival rate was significantly lower in patients with high survivin protein expression (P < 0.05). In cases with ALK protein expression, the prognosis was less favorable if there was also high co-expression of survivin protein (P < 0.05). In ALK protein negative cases, prognosis did not significantly correlate with the expression of survivin protein (P > 0.05). In addition, multivariate analysis confirmed the prognosis value of ALK protein expression, survivin protein expression and constitutional symptoms. CONCLUSION:Survivin protein expression can serve as an independent prognostic predictor of unfavorable clinical outcome in patients with ALCL, especially when ALK protein is positive.